Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.

Hepatology (Baltimore, Md.)
2018
https://researcherprofiles.org/profile/7229932
29476694
Huang AC, Mehta N, Dodge JL, Yao FY, Terrault NA